How Avmapki + Fakzynja Works

An interactive illustration of the RAS/MAPK pathway and the two-drug strategy that blocks it at two different points in KRAS-mutated low-grade serous ovarian cancer (LGSOC).

Cell surface Nucleus — decision to divide Growth signal receptor KRAS RAF MEK ERK FAK adhesion / survival Integrin adhesion receptor AVMAPKI FAKZYNJA CELL DIVIDES NORMALLY